Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTriple Point Ve Regulatory News (TPV)

Share Price Information for Triple Point Ve (TPV)

Share Price is delayed by 15 minutes
Get Live Data
86.00    0.00 (0.00%)
Bid:
84.50
Ask:
87.50
Spread: 3.00 (3.55%)
Market Cap: £113.74m
TPV Live PriceLast checked at - London Stock Exchange

Intraday Triple Point Ve Share Chart

Directorate Change

29 Sep 2011 14:44

RNS Number : 2202P
TP70 VCT Plc
29 September 2011
 



Directorate Changes

 

TP70 VCT plc (the "Company") announces the appointment of Richard Rose as an additional independent non-executive Director of the Company with effect from 22 September 2011.

 

Richard qualified as a solicitor in 1977. He joined Surrey legal firm, Morrisons Solicitors LLP, in 1988, and set up the firm's company and commercial team in 1994. He was managing partner for 11 years, prior to becoming senior partner in 2008.

 

Following this change the Company's board will comprise Michael Sherry, Chad Murrin, David Parsons and Richard Rose.

 

For and on behalf of TP70 VCT plc

Michael Sherry

Chairman

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOALLMJTMBITBTB
Date   Source Headline
2nd Apr 20251:33 pmRNSTotal Voting Rights
28th Mar 202512:00 pmRNSIssue of Equity and Total Voting Rights
26th Mar 20257:00 amRNSOffer for Subscription - over-allotment facility
17th Mar 202512:20 pmRNSIssue of Equity and Total Voting Rights
11th Mar 20253:13 pmRNSTransaction in Own Shares
11th Mar 202510:42 amRNSIssue of Equity and Total Voting Rights
3rd Mar 202510:46 amRNSTotal Voting Rights
26th Feb 202512:14 pmRNSIssue of Equity and Total Voting Rights
13th Feb 20259:10 amRNSOffer for Subscription - over-allotment facility
10th Feb 20252:10 pmRNSIssue of Equity and Total Voting Rights
30th Jan 20252:11 pmRNSVenture Share Class Net Asset Value
6th Jan 20257:00 amRNSDividend Declaration
2nd Jan 20257:00 amRNSTotal Voting Rights
23rd Dec 20247:00 amRNSOffer for Subscription - over-allotment facility
19th Dec 20243:07 pmRNSIssue of Equity and Total Voting Rights
2nd Dec 20247:05 amRNSIssue of Equity and Total Voting Rights
2nd Dec 20247:00 amRNSTotal Voting Rights
18th Nov 20244:00 pmRNSTransaction in Own Shares
12th Nov 20242:13 pmRNSIssue of Equity and Total Voting Rights
29th Oct 20244:05 pmRNSIssue of Equity and Total Voting Rights
23rd Oct 20247:00 amRNSResults for the six months ended 31 August 2024
2nd Oct 202410:59 amRNSDirector Declaration
30th Sep 20247:00 amRNSDividend Declaration
26th Sep 20243:30 pmRNSResult of General Meeting
4th Sep 202412:32 pmRNSPublication of a Prospectus and Circular
2nd Sep 202412:00 pmRNSTotal Voting Rights
9th Aug 20241:30 pmRNSTransaction in Own Shares
1st Aug 202410:30 amRNSTotal Voting Rights
1st Aug 20247:00 amRNSIntention to Launch an Offer for Subscription
31st Jul 20243:57 pmRNSIssue of Equity and Total Voting Rights
24th Jul 20247:00 amRNSVenture Share Class Net Asset Value
23rd Jul 20242:09 pmRNSResult of Annual General Meeting
4th Jul 20244:58 pmRNSTransaction in Own Shares
1st Jul 20244:42 pmRNSChange of Registered Office
1st Jul 20244:36 pmRNSTotal Voting Rights
27th Jun 20243:30 pmRNSIssue of Equity and Total Voting Rights
12th Jun 20245:29 pmRNSAnnual Financial Report and Notice of AGM
3rd Jun 20247:00 amRNSFinal Results for the year ended 29 February 2024
1st May 20247:00 amRNSTotal Voting Rights
5th Apr 20242:48 pmRNSIssue of Equity and Total Voting Rights
4th Apr 20243:01 pmRNSIssue of Equity and Total Voting Rights
2nd Apr 20242:00 pmRNSIssue of Equity and Total Voting Rights
2nd Apr 20247:00 amRNSTotal Voting Rights
26th Mar 20247:00 amRNSOffer for Subscription - over-allotment facility
18th Mar 20247:00 amRNSIssue of Equity and Total Voting Rights
5th Mar 20242:50 pmRNSIssue of Equity and Total Voting Rights
13th Feb 202412:30 pmRNSIssue of Equity and Total Voting Rights
9th Feb 20247:00 amRNSOffer for Subscription - over-allotment facility
8th Feb 20243:30 pmRNSVenture Share Class Net Asset Value
8th Feb 20242:00 pmRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.